Evidence Synthesis for Coverage Decisions and Clinical Policy
For health insurers, government payers and formulary committees, systematic evidence appraisal underpins every coverage determination and reimbursement negotiation. Puraite delivers the speed, structure and decision traceability that payers and regulators demand.
Request a Payer WalkthroughThe Challenge
Payers face mounting pressure to make faster, more defensible coverage and reimbursement decisions.
Coverage and Reimbursement Decisions
Payers rely on unbiased, systematically synthesised evidence to determine which drugs, devices or procedures to cover. Manual literature reviews delay formulary updates, reimbursement negotiations and coverage policy revisions, directly affecting member access and cost management.
Cost-Effectiveness and Value Assessment
Determining whether a new therapy provides sufficient clinical benefit over existing alternatives requires systematic comparison across outcomes, populations and settings. Synthesising this evidence manually across indications and comparators is resource-intensive.
Clinical Policy and Guideline Development
Payers use synthesised evidence to develop standard-of-care protocols, step-therapy requirements and prior authorisation criteria. Incomplete evidence searches or inconsistent quality assessment expose payers to legal and regulatory challenge.
Audit and Accountability
Regulators and stakeholders expect transparent, documented rationale for every coverage decision. Manual processes produce inconsistent documentation with gaps in the decision audit trail that are difficult to reconstruct under scrutiny.
How Puraite Helps
Specific workflows where Puraite accelerates regulated evidence work.
Formulary Evidence Review
Rapid systematic evidence appraisal for new drug and device coverage decisions. AI-assisted screening of clinical trials, real-world evidence and comparative effectiveness studies with structured quality assessment.
HTA Support (Payer Perspective)
Structured evidence synthesis supporting payer-side HTA processes. PICO-aligned searches, GRADE assessment workflow support (risk of bias, consistency, directness, precision, publication bias domains), and cost-effectiveness evidence mapping.
Prior Authorisation Evidence Base
Systematic review of clinical guidelines and primary evidence supporting prior authorisation criteria. Transparent documentation of the evidence behind each coverage restriction or step-therapy requirement.
Comparative Effectiveness Research
Cross-indication and cross-therapy evidence synthesis for benefit-risk assessments. Structured data extraction for indirect treatment comparisons and network meta-analysis inputs.
Ready to accelerate your evidence appraisal?
See how Puraite supports payer evidence workflows. Request a 30-minute walkthrough.